About Phathom Pharma (PHAT)
Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule pot... Read more
- USD12.46
- USD13.85
- USD12.26
- USD19.50
- 5.60%
- 114M
- 1.97M
- 1.29M
- 839M
- 2.21
- -18.20%
Stock News
yesterday
This AI stock has soared 1,600% in three years — and Deutsche Bank predicts more gains
MarketWatch
yesterday
Apple wants more sports rights, change how broadcasts are done, Eddy Cue says
CNBC
yesterday
Trump says he might attend Supreme Court tariff case arguments
CNBC
yesterday
Verra Mobility schedules third quarter 2025 earnings call
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
